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Abstract
Production of type I interferons (IFN-I, mainly IFNa and IFNb) is a hallmark of innate immune responses to all classes of
pathogens. When viral infection spreads to lymphoid organs, the majority of systemic IFN-I is produced by a specialized
‘‘interferon-producing cell’’ (IPC) that has been shown to belong to the lineage of plasmacytoid dendritic cells (pDC). It is
unclear whether production of systemic IFN-I is generally attributable to pDC irrespective of the nature of the infecting
pathogen. We have addressed this question by studying infections of mice with the intracellular bacterium Listeria
monocytogenes. Protective innate immunity against this pathogen is weakened by IFN-I activity. In mice infected with L.
monocytogenes, systemic IFN-I was amplified via IFN-b, the IFN-I receptor (IFNAR), and transcription factor interferon
regulatory factor 7 (IRF7), a molecular circuitry usually characteristic of non-pDC producers. Synthesis of serum IFN-I did not
require TLR9. In contrast, in vitro–differentiated pDC infected with L. monocytogenes needed TLR9 to transcribe IFN-I mRNA.
Consistent with the assumption that pDC are not the producers of systemic IFN-I, conditional ablation of the IFN-I receptor
in mice showed that most systemic IFN-I is produced by myeloid cells. Furthermore, results obtained with FACS-purified
splenic cell populations from infected mice confirmed the assumption that a cell type with surface antigens characteristic of
macrophages and not of pDC is responsible for bulk IFN-I synthesis. The amount of IFN-I produced in the investigated
mouse lines was inversely correlated to the resistance to lethal infection. Based on these data, we propose that the
engagement of pDC, the mode of IFN-I mobilization, as well as the shaping of the antimicrobial innate immune response by
IFN-I differ between intracellular pathogens.
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Introduction
Type I interferons (IFN-I) comprise a family of around 20
members that bind a common receptor, the type I IFN receptor
(IFNAR) [1]. Immunologically most relevant are IFNb,w i t ho n l y
one member in humans and mice, and the IFNa family with more
thantenmembers.Pattern recognition receptors(PRR) forall classes
of microbes are able to stimulate transcription of the IFN-I genes,
establishing IFN-I production as a hallmark of innate immune
responses to a vast number of viral and nonviral pathogens [2–8]. A
common property of these receptors is to stimulate the activation of
one or more transcription factors of the interferon regulatory factor
(IRF) family, most importantly IRF3 and IRF7 [9].
Cells producing IFN-I employ different molecular strategies to
induce synthesis of the cytokines. A feed-forward amplification
mode is characterized by IRF3-dependent IFNb production that
predominates the early phase of infection. In a subsequent phase
signaling of the IFNb through the IFNAR stimulates activation of
the transcription factor ISGF3 consisting of a STAT1/STAT2
heterodimer in conjunction with IRF9 [10]. This transcriptional
complex activates the IRF7 gene promoter and initiates expression
of the IRF7 mRNA. Finally, IRF7 is instrumental in transcribing
multiple IFNa genes in addition to IFNb [11]. An alternative way
of stimulating IFN-I was described for virus-infected or toll-like
receptor (TLR) ligand-stimulated plasmacytoid dendritic cells and,
under certain conditions, myeloid dendritic cells (pDC and mDC,
respectively) [12–14]. In these cells, the IFN-I genes are targeted
by a pathway originating from endosomal TLRs (TLR 7 and TLR
9) that assemble a signalosome including MyD88 and IRF7
together with other IRFs such as IRF1 or IRF5 [15–20]. In pDC
the TLR signal is rapidly relayed to IRF7, which is available for
immediate stimulation of all IFN-I promoters. Thus, pDC produce
vast quantities of IFN-I in response to infection with viruses and
are generally referred to as interferon-producing cells (IPC).
PLoS Pathogens | www.plospathogens.org 1 March 2009 | Volume 5 | Issue 3 | e1000355Listeria monocytogenes is a Gram-positive, food-borne bacterial
pathogen [21]. Major sites of Listeria replication during systemic
infection of mammals are liver and spleen. Infection is exacerbated
by the activity of IFN-I, shown convincingly by the increased
resistance of IFNAR or IRF3-deficient mice to lethal infection
[22–24]. Several explanations for this IFN-I effect have been
provided, including decreases in TNF production or an enhance-
ment of macrophage death [22–25]. Moreover, IFN-I were shown
to sensitize cytotoxic T lymphocytes to the lytic action of LLO
[24]. Enhanced lymphocyte killing and IL-10-dependent suppres-
sion of innate immunity as a result of phagocytic uptake of
apoptotic cells increase the severity of infection-borne pathological
effects [26].
L. monocytogenes is endowed with the ability to infect the
cytoplasm of cells in the host organism [27]. This ability results
from the endo/phagosome-disrupting activity of the major L.
monocytogenes virulence factor, the Listeriolysin O (LLO), a bacterial
cholesterol-dependent hemolysin [28]. A common property of L.
monocytogenes and viruses is that recognition and signaling occur
through both membrane-associated and cytosolic PRR [3]. In
contrast to viruses, the cytosolic L. monocytogenes receptors
mediating IFN-I induction have not been identified. In L.
monocytogenes-infected macrophages, IFN-I synthesis occurs via
feed-forward amplification [29]. The exact pathway and cell type
responsible for IFN-I production during infection of mice with L.
monocytogenes have not been examined. Considering the fact that
IFN-I enhance the adverse effects of the early, innate immune
response to L. monocytogenes [22–24], it is of major importance to
understand their mobilization and mode of action.
In this study we sought to identify the essential IFN-I-producing
cells during infection with L. monocytogenes. We used sorted splenic
cell populations and multiple mouse models with defects in the
IFN-I production machinery or with tissue-specific disruption of
the ifnar1 gene to decipher the pathways and cells required for
both IFNb and IFNa production. Our results show that in contrast
to viral infection models, pDC are not the source of IFN-I in
response to L. monocytogenes. Rather, the cytokines are produced via
feed-forward amplification by a splenic cell with cell surface
markers characteristic of macrophages. We also show for the first
time that IFNb and IRF7 make strong contributions to the
harmful action of IFN-I in L. monocytogenes infection because the
lower levels of IFN-I production in these mouse lines were
correlated with decreased susceptibility to lethal infection.
Results
Prerequisites for IFN-I production in mice and cells
infected with L. monocytogenes
Knock-out mice were used to study pathways contributing to
increase of IFNb and IFNa in the serum of mice infected with L.
monocytogenes. We established 24 h post intraperitoneal (i.p.)
injection of bacteria as the point of maximum IFN-I induction
in preliminary experiments (data not shown); therefore, IFNb and
IFNa were measured 24 h after infection with L. monocytogenes in
subsequent experiments. Serum levels of IFNb were generally at
the detection limit of the ELISA and differences between wt and
the IRF32/2 or IRF72/2 genotypes could not be reliably
determined. By contrast, statistically significant differences were
observed comparing wt and IFNAR12/2 animals (Figure 1A).
This finding most likely reflects the importance of the IFNAR for
IFNb clearance. Increased accumulation of the cytokine in the
blood of IFNAR2/2 mice is therefore not in contradiction to
subsequent findings showing that a fraction of IFNb production
occurs via feed-forward amplification through the IFNAR (e.g.
Figures 2 and 3). Serum of infected wt mice contained higher
levels of IFNa than IFNb. IFNa species were reduced in absence
of IFNb, IRF3 or IRF7 (Figure 1B). Serum IFNa was virtually
absent in mice lacking IFNAR1. Collectively the data show that
the levels of serum IFNa critically depend on ‘early’ IFNb and on
IFN-I signaling, hence feed-forward amplification. Bacterial loads
in liver and spleen after 24 h of infection were virtually identical
between wt and IFNAR2/2 mice (Figure S1). Therefore,
differences in IFN-I production did not result from lower numbers
of infecting bacteria.
The spleen is a major target organ of L. monocytogenes,
irrespective of the route of infection by intragastric, intraperitoneal
or intravenous application [21,30]. Therefore, we tested both IFN-
I production and response in spleens following infection with L.
monocytogenes (Figure 2A and 2B, and Figure S2A). Production of
both IFNb and IFNa mRNA, assayed by RT-PCR (Figure 2A and
2B), was observed in wt animals. IFNb mRNA synthesis required
both IRF3 and IRF7 and, surprisingly, the IFNAR. Splenic IFNa
production was reduced in absence of IRF3 or IFNb and even
more affected by the lack of IRF7 or the IFNAR. A representative
analysis of four mice/genotype is shown in Figure 2A, whereas
Figure 2B summarizes all experiments to show how many mice of
each genotype produced IFN-I and account for individual
responses to Listeria infection.
STAT2 is a subunit of the ISGF3 transcription factor complex
and its tyrosine phosphorylation is a hallmark of IFN-I-treated
cells [10]. Phosphorylated STAT2 was absent in IFNAR12/2
spleens, reduced slightly in absence of IFNb and IRF3, and
reduced strongly in absence of IRF7 (Figure S2A). STAT1
tyrosine phosphorylation occurs in response to both IFN-I and
IFNc [10]. Likewise, the STAT target gene Gbp2 (Figure 2A)
responds to both IFN types. Both STAT1 tyrosine phosphoryla-
tion and Gbp2 expression occurred at levels similar to wt in all
genotypes including IFNAR12/2 (Figure S2A). In agreement
with this, IFNc mRNA levels were equal to wildtype in all
investigated genotypes (data not shown). Together the data show
that the molecular requirements for splenic IFN-I production are
Author Summary
Type I Interferons (IFN-I) are cytokines produced by the
innate immune system immediately after intrusion of a
pathogen. To produce large quantities of IFN-I once an
infection is starting to spread throughout the body, the
innate immune system employs a specialized ‘‘interferon-
producing cell’’ (IPC). In the case of viral infections, IFN-I
protect the host organism from rapid viral replication and
spread. Conversely, organisms that cannot produce IFN-I
are exquisitely sensitive to viral infections. Intriguingly, the
opposite has been reported for the pathogen Listeria
monocytogenes. Like virus, this bacterium replicates within
cells of the host organism and stimulates IFN-I synthesis.
Unlike virus, however, IFN-I sensitize the infected host to
lethal pathology resulting from L. monocytogenes infection.
In this article, we show that all tested molecules
contributing to IFN-I production in Listeria-infected mice
are responsible for a corresponding increase in mortality.
We address the question of which cell type is responsible
for producing vast quantities of IFN-I that can be measured
in the serum of mice infected with Listeria. We show that
these are not IPC, but rather macrophages, cells special-
ized to ingest and kill bacteria. We conclude that the
engagement of cells for IFN-I production and also the
effect of IFN-I on innate immunity is determined by the
tropism and lifestyle of a particular pathogen.
Interferon Production upon Infection with Listeria
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cases signaling through IFNAR and upregulation of IRF7
expression are of critical importance and indicate feed-forward
amplification.
In bone-marrow-derived macrophages (BMM), L. monocytogenes
stimulates IFNb synthesis through the IRF3 pathway independently
of TLR9 and MyD88 [29,31]. Requirements for IFN-I production
were further investigated in BMM and mDC infected with L.
monocytogenes. IRF7 or IFNAR-deficiency had no effect on BMM
IFNb production (Figure 2C). Unlike IFNb, IFNa production by
infected BMM was dependent on IRF3, IRF7, IFNb and the
IFNAR (Figure 2D). In case of IRF7-deficiency, residual IFN-I still
caused unimpaired tyrosine phosphorylation of STAT2 (Figure
S2B). In mDC, surprisingly, both IFNb and IFNa production
strictly required IRF3, IRF7 and IFNAR1 (Figure 2E and 2F).
Prerequisites for the increase in resistance to lethal
infection caused by IFN-I
To investigate the contribution of IFNb and IRF7 to the IFN-I-
dependent increase in mortality, we monitored the survival of
animals infected with L. monocytogenes. In accordance with previous
findings [22–24], IFNAR deficiency caused a strong resistance to
lethal infection, particularly during the innate phase of the anti-
Listeria immune response (up to day 6, Figure 4A). By
comparison, the increase caused by IFNb deficiency was less
pronounced. Lack of IRF7 had a greater impact on survival than
absence of IRF3. This difference became smaller if survival was
monitored beyond the period of the innate immune response (up
to day 10). Lower pathogen burdens in liver and spleens from
IRF7 or IFNb-deficient mice reflected the increase in survival on
day 3 (Figure 4B). Similar findings have been reported for
IFNAR1 and IRF3-deficient mice [22–24]. Since differences in
the bacterial load between wt animals and those with defects in
IFN-I synthesis and/or response are not present 24 h after
infection (Figure S1) the inhibitory effect of IFN-I on bacterial
clearance must develop between day 1 and 3 post infection.
Together, the data emphasize the importance of the early IFNAR,
IFNb and IRF7-mediated amplification of IFN-I production for
adverse IFN-I action during the early, innate immune response.
Myeloid cells contribute to IFN-I production and the IFN-
I–dependent sensitization of mice to lethal infection with
L. monocytogenes
To examine the cell type(s) important for IFN-I production and
response during L. monocytogenes infection, we made use of tissue-
specific IFNAR ablation. The contribution of myeloid cells to
IFN-I effects was tested by mating mice with a floxed ifnar1 allele
[32] with LysM-Cre mice [33]. Using this technology, a high
degree of floxed allele conversion is obtained in macrophages and
neutrophils, whereas it is inefficient in splenic DC [33]. In
accordance with these observations, IFNAR1 expression in
IFNAR
fl/fl-LysM-Cre mice was strongly reduced in CD11b
+
cells that include macrophages, but similar to wt on CD11c
+ cells
that include myeloid and plasmacytoid DC (Figure S3). Absence
of the IFNAR in myeloid cells caused a highly significant increase
in the survival of Listeria-infected mice during the innate phase of
the immune response up to day 6 (Figure 3A). In this period we
observed 100% survival in mice with complete IFNAR1 deletion
and 80% survival in mice with myeloid IFNAR1 deletion. At
later times the survival curves diverged further, most likely due to
a contribution of non-myeloid cells to the lethal outcome of
infection. The increase in survival compared to wt mice could
result from an important role of myeloid cells in IFN-I
production. Alternatively, the myeloid response to IFN-I might
directly contribute to the cytokines’ detrimental action. To
distinguish between these possibilities, serum IFN–I was com-
pared in wt mice and mice lacking the IFNAR either on all or
only on myeloid cells. This experiment revealed a major
contribution of myeloid cells to serum IFNa by IFNAR-
dependent feed-forward amplification (Figure 3B). Differences
in the low level of serum IFNb were not statistically significant
between wt mice and those disrupted for the myeloid ifnar1 gene
(data not shown).
Analysis of splenic IFN-I production and response in mice
lacking the myeloid IFNAR showed that IFNa mRNA was
completely absent (Figure 3C). Residual IFNb mRNA was present,
but the induction was reduced and more transient (compare 24 h
and 48 h time points). No difference between genotypes was
observed for the induction of Gbp2.
Figure 1. Serum levels of IFN-I in mice deficient in components of the IFN-I signaling pathway. Mice of the indicated genotypes were
injected intraperitoneally (i.p.) with 5610
6 L. monocytogenes (C57BL/6 n=25, IFNb2/2 n=25, IFNAR12/2 n=24, IRF32/2 n=25, IRF72/2 n=20) or
PBS as a control (data not shown). After 24 h, serum was collected and ELISAs for IFNb (A) and IFNa (B) were performed. The data presented here are
a summary of several individual experiments with groups of four to five infected mice per genotype. Data representing IFNb (A) and IFNa (B)
concentrations were log-transformed (after adding one) to achieve approximate normality. Linear models with genotype and experiment as fixed
effects were fitted using SPSS. Means plus/minus standard errors of wt and mutant genotypes are plotted (after back-transformation). Significant
values are indicated by: n.s. not significant p.0.05, * p#0.05, ** p#0.01, *** p#0.001.
doi:10.1371/journal.ppat.1000355.g001
Interferon Production upon Infection with Listeria
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infected hosts is independent of the TLR9 pathway
The data collected so far suggest that the majority of IFN-I is
produced by a splenic cell type that employs an IFNb/IFNAR/
IRF7 pathway for feed-forward amplification of IFNa synthesis.
This profile does not match IFN-I production by pDC where
expression of IFN-I genes is regulated by a pathway originating
from endosomal TLRs [34]. To further exclude the relevance of
this pathway for IFN-I production during Listeria infection,
TLR9-deficient mice were analyzed. The data summarized in
Figure 5 show that neither serum IFNb or IFNa (Figure 5A and
5B), nor splenic IFN-I mRNA synthesis or response were reduced
in the absence of TLR9 (Figure 5C, Figure S4A). By contrast,
production of IFN-I mRNA in bone-marrow-derived pDCs
exposed to L. monocytogenes showed strong (IFNb) or absolute
(IFNa) dependence on TLR9 and/or MyD88 (Figure 5D–5F).
Both IFNb and IFNa mRNA synthesis were strongly affected by
IRF7 deficiency and, surprisingly, also the absence of IRF3
(Figure 5G and 5H). Unlike pDC, mDC produced IFNb
independently of the TLR9 pathway, resembling macrophages
in this regard (Figure S4B). Consistent with IFN-I production
(Figure 5A–5C), the absence of TLR9 did not increase survival
following infection with L. monocytogenes (Figure 5I). Rather, TLR9
deficiency slightly enhanced the lethality of L. monocytogenes
infection, suggesting that the TLR9 pathway plays a protective
role.
Cells with a surface profile characteristic of macrophages
are the IFNa producers in L. monocytogenes–infected
spleens
To further rule out pDC as major producers of IFN-I during
Listeria infection of mice and to confirm a prominent role of
myeloid cells, we purified cell populations from L. monocytogenes
infected spleens by FACS and measured IFN-I production by RT-
Figure 2. Prerequisites for IFN-I production in infected spleens and in vitro–generated BMM and mDCs. Mice of the indicated genotypes
were injected i.p. with 5610
6 L. monocytogenes or PBS as a control. After 24 h of infection, mice were killed and spleens and livers isolated. (A) RNA
was extracted from spleens of four infected mice per genotype (1–4) or from mice injected with PBS (2), and RT-PCR for the indicated genes was
performed. As a normalization control, the housekeeping gene L32 was measured. (B) Summary of experiments performed with mice of the indicated
genotypes. In total, 20 C57BL/6, 20 IFNb2/2, 19 IFNAR12/2, 20 IRF32/2, and 15 IRF72/2 mice were analysed for IFN-I expression and expression
of Gbp2. The graph shows the percentage of mice of the respective genotypes showing detectable IFNa (black) or IFNb (grey) expression after
infection with 5610
6 L. monocytogenes for 24 h. (C–F) BMM (C,D) or mDC (E,F) of the indicated genotypes were infected with L. monocytogenes at a
MOI of 10. At the indicated time points, total RNA was prepared. The isolated RNA was reverse-transcribed and induction of the IFNb (C,E) or IFNa
genes (D,F) was measured by real-time PCR. For normalization to a housekeeping gene, GAPDH was measured.
doi:10.1371/journal.ppat.1000355.g002
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pDC (PDCA1
+B220
+CD11c
dimCD11b
2) fail to produce IFN-I in
response to L. monocytogenes infection. The CD11c
hi population
(either CD11b
+PDCA1
2B220
2 or CD11b
2PDCA1
2B220
2)
including typical mDCs did not express detectable IFNa mRNA,
whereas these cells produced minor amounts of IFNb mRNA. In
contrast, CD11b
+ cells not expressing CD11c, PDCA1 or B220, a
profile characterizing macrophages, expressed high levels of both
IFNa and IFNb mRNA. Macrophages, therefore, are most likely
the predominant IFN-I producers in Listeria-infected mice.
Discussion
Using mice and cells ablated for genes involved in IFN-I
synthesis, we established a molecular profile of the cell type(s)
producing IFN-I upon infection with L. monocytogenes and correlated
Figure 3. Myeloid cells strongly contribute to IFN-I production. (A) C57BL/6 wt (n=13), IFNAR12/2 (n=4), and mice with LysM-Cre-
mediated deletion of IFNAR1 (LysMCre-IFNAR1
fl/fl, n=9) were infected with 5610
6 L. monocytogenes, and survival was monitored for ten days. (B)
Mice of the indicated genotypes were infected with 5610
6 L. monocytogenes (seven mice per group) or injected with PBS (two mice per group). After
24 h, serum was collected and ELISA was performed for IFNb (data not shown) and IFNa levels. Data representing IFNa concentrations were log-
transformed to achieve approximate normality. Linear models with genotype as fixed effect were fitted using SPSS. Means plus/minus standard errors
of wt and mutant genotypes are plotted (after back-transformation). Significant values are indicated by ** p#0.01, *** p#0.001. (C) Mice of the
indicated genotypes were infected with 5610
6 L. monocytogenes (1–3) or injected with PBS (2). After 24 h and 48 h, spleens were isolated and RNA
was extracted. The RNA was reverse-transcribed and subjected to PCR for the indicated genes. As a normalization control, the housekeeping gene
L32 was measured.
doi:10.1371/journal.ppat.1000355.g003
Figure 4. Prerequisites for the increase in resistance to lethal infection caused by IFN-I. (A) Mice of the indicated genotypes were infected
with 5610
6 L. monocytogenes, and survival was monitored for ten days. The data presented here are a summary of several individual experiments
with groups of 4–6 mice per genotype and treatment. Total number of mice analysed are: C57BL/6 wt n=34, IFNAR12/2 n=23, IFNb2/2 n=23,
IRF32/2 n=24, IRF72/2 n=29. (B) Groups of ten (C57BL/6 wt and IFNb2/2) or eight (IRF72/2) mice were infected with 1610
6 L. monocytogenes.
After three days, mice were killed and the L. monocytogenes titre was determined in the liver and spleen and presented as CFU. Data were log-
transformed to achieve approximate normality. Linear models with genotype as fixed effect were fitted using SPSS. Significant values are indicated
by: n.s. not significant p.0.05, *** p#0.001.
doi:10.1371/journal.ppat.1000355.g004
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infected hosts. Clear results emerging from our studies are that I) the
TLR9/MyD88 pathway, a hallmark of IFN-I synthesis by pDC,
does not significantly contribute to splenic (local) or systemic IFN-I
production; II) consistently, feed-forward amplification requiring
signaling through the IFNAR is of great importance and III) the
main IFN-I producers are cells with characteristics typical of splenic
macrophages. Finally and IV), IFNb and IRF7 contribute to the
enhancement of lethal infection by IFN-I. Reduction in IFN-I
production that resulted from IRF3, IRF7, IFNb or IFNAR
deficiency by and large reflected the increase in resistance to lethal
infection. Examination of pathogen organ loads revealed that the
bacterial growth-promoting, hence lethality-enhancing activity of
IFN-I develops between day 1 and 3 post infection.
Our studies focused on the early, innate phase of infection up to
about day 6. IFN-I may additionally influence the ensuing
adaptive immune response and, as suggested by recent studies,
this effect may not be primarily adverse as in the innate response
[35–37]. Diverse IFN-I effects on adaptive and innate immunity
most likely explain that the relative increases in resistance to
infection caused by the knock-out mice used in our study differ to
some degree when analyzed at day 6 or day 10 after infection
(Figure 4). Furthermore, the survival curve of mice with myeloid
cell-specific IFNAR1 ablation suggests that cells outside this cell
compartment influence the survival of Listeria infection particu-
larly after the innate phase of the immune response.
Two recent studies closely examining the innate response to
Listeria in infected spleens revealed a highly complex process
Figure 5. The role of TLR9 in mice and cells infected with L. monocytogenes. (A–C) C57BL/6 wt or TLR92/2 mice were injected i.p. with
5610
6 L. monocytogenes (four mice per genotype) or PBS as a control (data not shown). After 24 h of infection, serum was collected and ELISAs for
IFNb (A) and IFNa (B) were performed. Data representing IFNb (A) and IFNa (B) concentrations were log-transformed (after adding one) to achieve
approximate normality. Linear models with genotype as fixed effect were fitted using SPSS. Means plus/minus standard errors of wt and mutant
genotypes are plotted (after back-transformation), n.s.: not significant (p.0.05). (C) After 24 h of infection, mice were killed and spleens isolated. RNA
was extracted from spleens of three infected mice per genotype (1–3) or from mice injected with PBS (2), and RT-PCR for the indicated genes was
performed. As a normalization control, the housekeeping gene L32 was measured. (D–H) pDCs of the indicated genotypes were infected with L.
monocytogenes at a MOI of 10. At the indicated time points, total RNA was prepared. The isolated RNA was reverse-transcribed, and induction of the
IFNb (D,E,G) or IFNa (F,H) genes was measured by real-time PCR. For normalization to a housekeeping gene, GAPDH was measured. (I) C57BL/6 wt or
TLR92/2 mice (13 mice per genotype, data represent a summary of two experiments) were injected i.p. with 5610
6 L. monocytogenes. Survival was
monitored for ten days.
doi:10.1371/journal.ppat.1000355.g005
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+ DC for the movement of Listeria to the white
pulp and to initiate a concerted response involving macrophages,
TIP-DC, NK cells and neutrophils [38,39]. Our study shows that
the TLR9 pathway was not engaged by L. monocytogenes for IFN-I
synthesis in mice. By contrast, data with pDC-enriched bone
marrow cultures show that Listeria can present a TLR9 ligand and
stimulate this cell type for IFN-I production. This finding strongly
implies that pDC do not contribute to IFN-I production during L.
monocytogenes infection of mice, in spite of high bacterial loads in
lymphoid organs that harbor this cell type. Although TLR9/
MyD88-independent IFN-I synthesis has also been observed in
mice infected with viruses [40–42], several reports suggest that the
engagement of the pDC/TLR system for IFN-I production occurs
when viruses gain access to lymphoid tissue either directly or
because the pathogen breaks the initial barrier of infection formed
by macrophages and/or epithelial cells [34,41–43]. For example,
lung infection with Newcastle disease virus led to IFNa production
by alveolar macrophages, whereas systemic infection engaged both
mDC and pDC for IFNa production [41]. Splenic mDC are
reportedly major IFN-I producers during infection with Adeno-
virus, underscoring pathogen specificity in the choice of IPC and
defying a general role of pDCs as producers of systemic IFN-I
upon viral infection [44]. Under steady state conditions, pDC are
mainly found in peripheral blood and lymphoid organs [13]. A
recent report by Tam and Wick demonstrated expansion and
activation of cells phenotypically resembling pDC in lymphoid
tissue infected with L. monocytogenes [45]. The cells expressed
activation antigens, but, consistent with our results, did not
produce cytokines. Together, the data suggest that the ability of L.
monocytogenes to stimulate pDC expansion occurs without direct
contact and may be caused by cytokines released from infected
cells. Unlike virus, L. monocytogenes appears to be unable to
efficiently gain access to pDC even at lethal doses of infection
when lymphoid organs are heavily infected. Direct contact may be
prevented by an efficient containment of the pathogen in cells that
are more readily infected than pDC. Owing to their phagocytic
potential, splenic macrophages activated by NK cell-derived IFNc,
might clear Listeria before they reach pDC. It will be interesting to
determine whether the choice of IPC determines the IFN-I effect
on infection and whether macrophages as IFN-I producers are
related to fatal outcome as in the case of L. monocytogenes. In this
regard it will be important to examine IPCs in murine infection
models such as S. pneumoniae, where the host benefits from the
production of IFN-I [46].
IFNa production in BMM via feed-forward amplification
required IRF3-dependent IFNb production, signaling through
IFNAR1 and IRF7. This resembled the molecular mechanism
observed for splenic or systemic IFNa production after in vivo
infection. To confirm the assumption that cells different from pDC
are important IFNa producers in vivo we used IFNAR
fl/fl-LysM-
Cre mice and demonstrated that IFNa synthesis critically depends
on the presence of IFNAR1 on myeloid cells. Consistently, cells
expressing surface markers characteristic of macrophages express
both IFNb and IFNa mRNA when purified from infected spleens.
By contrast, this was not observed for the cell populations that
include mDC and pDC. Thus, macrophages are the most likely
IFNa producer cells after L. monocytogenes infection in vivo.A n
additional contribution of neutrophils cannot be ruled out entirely.
However, little is known about the presence and abundance of this
cell type in the spleen early after Listeria infection and it is
similarly unclear whether neutrophils produce IFN-I in response
to infection.
Whereas IRF3 was also critically involved in IFNb production
by bone marrow-derived macrophages, the IFNAR or IRF7 were
not required. This contrasts the more important role of IRF7 for
IFNb synthesis in the L. monocytogenes infected spleen. Unlike bone
marrow macrophages, much of splenic IFNb resulted from an
IFNAR/IRF7-dependent amplification loop because IFNAR2/2
spleens expressed strongly reduced amounts of IFNb mRNA. This
may reflect a contribution of splenic mDC to IFNb production.
This cell type required IRF3 as well as IFNAR/IRF7 for IFNb
synthesis also when grown from mouse bone marrow. We assume
that mDC produce low amounts of IFNb immediately after
Listeria infection in an IRF3-dependent manner. This initiates the
feed-forward amplification loop causing synthesis of the majority
of both IFNb and of IFNa. This model, while consistent with the
data, fails to provide a satisfactory explanation for the obvious
difference between bone marrow-derived macrophages and mDC
regarding the significance of IFNAR1/IRF7 for IFNb synthesis.
Possibly the much larger rate of cytoplasmic infection of
macrophages drives IRF3-dependent IFNb synthesis much more
efficiently. A deeper understanding of cell type differences in the
mode of IFN-I production is needed to provide ultimate clarity
regarding this point. The assumption that splenic mDC participate
in IFNb production via IFNAR and IRF7 in infected mice is
supported by the presence of mRNA for the cytokine in CD11c
+/
CD11b
+ cells purified from infected mice. Nonetheless, a larger
amount of IFNb mRNA was detected in purified splenic
macrophages, suggesting a major contribution of these cells to
total IFNb production. At the same time, a large fraction of splenic
IFNb requires feed-forward amplification and, judging from our
findings with BMM, this appears to contrast the assumption of
macrophages being major producers. A simple explanation for this
discrepancy might be an intrinsic difference between splenic
macrophages and BMM regarding feed-forward amplification of
IFNb production. Alternatively, the IFNAR/IRF7 requirement of
Figure 6. Macrophages and not pDC are the IFN-I–producing
cells after L. monocytogenes infection. C57Bl/6 wt mice (n=15)
were infected with 5610
6 L. monocytogenes. After 24 h, mice were
killed, splenic cells were isolated, labelled with antibodies against
CD11b (FITC-conjugated), CD11c (APC), PDCA1 (PE-Cy5), and B220 (PE-
Cy7), and subjected to FACS sorting. RNA of the isolated cell
populations was extracted, reverse-transcribed, and subjected to PCR
for the indicated genes. Unsorted cells and whole spleen extracts from
infected spleens (crude extract) as well as uninfected spleens were used
as controls. As a positive control for the PCR reactions, Raw264.7
macrophages were infected (+) or not (2) with L. monocytogenes for 8 h
at a MOI of 10. As a negative control, H2O was used instead of template
cDNA. As a normalization control, the housekeeping gene L32 was
measured.
doi:10.1371/journal.ppat.1000355.g006
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amplification results from paracrine, not autocrine IFN-I priming.
Under this assumption IFN-I is released by infected macrophages
within or outside the spleen to prime uninfected splenic
macrophages. Signaling through the IFNAR will result in IRF7
expression and the transcription factor is available for both IFNb
and IFNa production once primed cells become infected by
Listeria. By contrast BMM are synchronously infected in culture
and will immediately produce IFNb in absence of IRF7
expression, employing exclusively IRF3 instead.
In summary our results provide answers to the question how the
IFN-I system is deployed by an intracellular bacterial pathogen.
Both, the observations made with cultured cells and our studies in
mice, emphasize that molecular mechanisms governing IFN-I
synthesis and response strongly depend on the pathogen as well as
the host cell type. Deciphering the importance of these differences
for various routes of infection and for diverse types of pathogens
remains a challenging task for future research.
Materials and Methods
Ethics Statement
All animal experiments were discussed and approved by the
University of Veterinary Medicine, Vienna institutional ethics
committee and carried out in accordance with protocols approved
by the Austrian law (GZ 680 205/67-BrGt/2003).
Bacteria
Listeria monocytogenes LO28 [47] were grown in brain heart
infusion (BHI) (Difco) broth. Concentrations of bacteria were
determined by measurement at OD600 and confirmed by plating
serial dilutions onto BHI or Oxford agar (Merck) plates.
Mice
All mice were on a C57BL/6 background and housed under
specific pathogen-free conditions according to FELASA guidelines
[48].
Cells
Raw264.7 macrophages were cultured in DMEM (Gibco,
Invitrogen) supplemented with 10% FCS (Gibco, Invitrogen).
Bone marrow was isolated from femurs of 6–8 week old mice. For
differentiation of BMM, cells were grown in DMEM (Gibco,
Invitrogen) in the presence of 10% FCS (Gibco, Invitrogen) and L-
cell derived CSF-1 as described [49]. The cultures contained
.99% F4/80
+ cells. mDCs were obtained by culture of bone
marrow in DMEM (Gibco, Invitrogen) supplemented with 10%
FCS (Gibco, Invitrogen) and X-6310 derived GM-CSF as
described [50]. mDC cultures contained virtually no F4/80+ cells
and the purity of CD11c
+/CD11b
+ cells was between 60 and
70%. pDCs were obtained by culture of bone marrow in DMEM
(Gibco, Invitrogen) supplemented with 50 ng/ml of Flt-3-L for 6
days. The purity of CD11c
dim/B220
+ pDCs was between 60 and
70%. pDC cultures contained no F4/80
+ cells.
Infection of cells
Raw264.7 macrophages, primary BMM, mDCs and pDCs were
infected with L. monocytogenes (derived from overnight culture) at a
multiplicity of infection (MOI) of 10 and incubated for 60 min at
37uC in a humidified CO2 atmosphere. Extracellular bacteria
were subsequently killed by exchanging medium to gentamicin-
containing medium (final concentration 50 mg/ml). After another
60 min, medium was changed to medium containing 10 mg/ml
gentamicin.
Infection of mice
Listeria monocytogenes was grown in BHI broth (Difco) to late
logarithmic phase (OD600 0.8), pelleted and resuspended in BHI
containing 20% glycerol. Aliquots were shock-frozen and stored at
280uC. The concentration of L. monocytogenes aliquots was
quantified by plating serial dilutions onto Oxford agar plates
(Merck). For infection, the bacteria were thawn on ice, washed
with PBS for three times and diluted in PBS (endotoxin-free,
Sigma) to the appropriate concentrations. 500 ml of the bacterial
suspension were injected into the peritoneum of 10- to 12-week-
old mice. For the experiments shown, survival of infected mice was
monitored for 10 days. For determination of the bacterial load,
mice were killed at the indicated time points after infection and
spleens and livers were homogenized in PBS. Serial dilutions of
homogenates were plated on Oxford agar plates and colonies were
counted after growth at 37uC for 24–36 h. For RNA and protein
extraction from spleen and for sorting of splenic cells, mice were
killed after 24 h of infection and spleens were isolated.
ELISA
Mice were infected intraperitoneally with L. monocytogenes or
injected with PBS (Sigma). Sera were collected after 24 h of
infection and levels of IFNb and IFNa were determined by ELISA
according to the manufacturer’s instructions (PBL Interferon-
Source).
Fluorescence-activated cell sorting (FACS)
Spleens were digested in 1 mg/ml collagenase (Roche) for 10 min
and homogenized using a cell strainer. The cell suspension was
labelled with the following antibodies: CD11b2FITC (Becton
Dickinson), CD11c-APC (Becton Dickinson), B220-PE-Cy7(Beckton
Dickinson) and PDCA1-PE-Cy5 (Miltenyi Biotec). Four different cell
populations were sorted by FACS: PCDA1
+B220
+CD11c
dim (pDC),
CD11b
+CD11c
2B220
2PDCA1
2 (macrophages), CD11b
+CD11c
+
B220
2PDCA1
2 and CD11b
2CD11c
+B220
2PDCA1
2 (myeloid
dendritic cells).
RNA extraction and PCR
RNA extraction from cells, reverse transcription and real-time
PCR was performed as already described [29]. Data obtained by
real-time PCR were analysed using SPSS and a Student’s t-Test.
Significant values are indicated by: n.s. not significant p.0.05,
*p #0.05, ** p#0.01, *** p#0.001.
Primers for real-time PCR were as described, except for IFNa:
Probe: panIFNa:5 9-(6-Fam) AG+AA+GAA+A+C+AC+AG+CC
(BHQ1)-39 (+indicating LNA (Locked Nucleic Acid) nucleotides;
Proligo); panIFNa-for: 59-CCACAGGATCACTGTGTACCT-
GAGA-39; panIFNa-rev: 59-CTGATCACCTCCCAGGCA-
CAG-39
Spleens were isolated from mice infected with L. monocytogenes or
injected with PBS for 24 h, shock-frozen in liquid nitrogen and
stored at 280uC. For RNA extraction, 20 mg of frozen tissue was
homogenized in lysis buffer RA1 (NucleoSpin RNAII kit,
Macherey-Nagel) with the Precellys 24 homogenizer (Peqlab) at
6000 rpm for 30 sec. Subsequent isolation of total RNA and cDNA
synthesis was performed as described [29]. Primers used for
P C Rw e r ea sf o l l o w s :p a n I F N a-for-59-ATGGCTAG(A/G)CTC-
TGTGCTTTCCT-39; panIFNa-rev-59-AGGGCTCTCCAGA(T/
C)TTCTGCTCTG-39;I F N b-for 59-CATCAACTATAAGCAG-
CTCCA-39;I F N b-rev 59-TTCAAGTGGAGAGCAGTTGAG-39;
Gbp2-for-59-TGCTAAACTTCGGGAACAGG-39;G b p 2 - r e v - 5 9-
GAGCTTGGCAGAGAGGTTTG-39; L32-for 59-ATTAAGC-
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GCGTAGCCTGG-39.
Supplementary Materials and Methods are presented in Text
S1.
Supporting Information
Figure S1 Groups of 9 C57BL/6 wt or IFNAR12/2 mice were
infected with 5610
6L. monocytogenes. After 24 h of infection, mice
were killed and the L. monocytogenes titre was determined in the liver
and spleen and presented as CFU. Data were log transformed to
achieve approximate normality. Linear models with genotype as
fixed effect were fitted using SPSS. No significant differences
between genotypes were observed (n.s. not significant p.0.05).
Found at: doi:10.1371/journal.ppat.1000355.s001 (0.11 MB TIF)
Figure S2 A) Mice of the indicated genotypes were injected i.p.
with 5610
6L. monocytogenes or PBS as a control. After 24 h of
infection, mice were killed and spleens isolated. Protein was
extracted from spleens of four infected mice per genotype (1–4) or
from mice injected with PBS (2), and Western blot for the
indicated proteins was performed. STAT1 and STAT2 activation
was detected using antibodies recognizing phosphorylated tyrosine
701 and 689, respectively. As a positive control for STAT
phosphorylation, Raw264.7 macrophages were infected (+) or not
(2) with L. monocytogenes for 4 h at a MOI of 10, and protein
extracts were loaded onto the same gel. B) BMM derived from
mice of the indicated genotypes were infected with L. monocytogenes
at a MOI of 10. At the indicated time points, protein extracts were
prepared and subjected to Western blotting. STAT2 activation
was detected using an antibody recognizing phosphorylated
tyrosine 689. A+B) For control of equal loading, the blots were
reprobed with an antibody specific for the Erk kinases Erk1 and
Erk2 (panErk).
Found at: doi:10.1371/journal.ppat.1000355.s002 (1.23 MB TIF)
Figure S3 A–C) Splenocytes were isolated from C57BL/6,
IFNAR1fl/fl-LysMCre, and IFNAR12/2 mice and CD11b+
cells were enriched by magnetic activated cell sorting (MACS).
CD11b-enriched cell fraction was stained for CD11c and IFNAR1
and percentages of CD11c+IFNAR+ and CD11c+IFNAR2 cells
were determined by flow cytometry. D–F) CD11b-enriched
splenocytes were stained for CD11b and IFNAR1. IFNAR1
expression by cells gated for coexpression of CD11b was analysed
by flow cytometry. G) Peritoneal exudate cells were isolated from
wt C57/BL6 mice (solid line), IFNAR1fl/fl-LysMcre mice (dashed
line), and IFNAR12/2 mice (gray shaded curve). IFNAR1
expression by cells gated for coexpression of F4/80 (left diagram)
was determined by flow cytometry. As a control IFNAR1
expression on total lymphocytes (gated on lymphocytes in FSC/
SSC plot (not shown) was analysed.
Found at: doi:10.1371/journal.ppat.1000355.s003 (1.38 MB TIF)
Figure S4 A) C57BL/6 wt or TLR92/2 mice were injected i.p.
with 5610
6L. monocytogenes or PBS as a control. After 24 h of
infection, mice were killed and spleens isolated. Protein was
extracted from spleens of three infected mice per genotype (1–3) or
from mice injected with PBS (2), and Western blot for the
indicated proteins was performed. STAT1 and STAT2 activation
was detected using antibodies recognizing phosphorylated tyrosine
701 and 689, respectively. As a positive control for STAT
phosphorylation, Raw264.7 macrophages were infected (+) or not
(2) with L. monocytogenes for 4 h at a MOI of 10, and protein
extracts were loaded onto the same gel. For control of equal
loading, the blots were reprobed with an antibody specific for the
Erk kinases Erk1 and Erk2 (panErk). B) mDC of the indicated
genotypes were infected with L. monocytogenes at a MOI of 10. At
the indicated time points, total RNA was prepared. The isolated
RNA was reverse-transcribed and induction of the IFNb gene was
measured by Real-time PCR. For normalization to a house-
keeping gene, GAPDH was measured.
Found at: doi:10.1371/journal.ppat.1000355.s004 (0.28 MB TIF)
Text S1 Supplementary Materials and Methods
Found at: doi:10.1371/journal.ppat.1000355.s005 (0.03 MB
DOC)
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